Lara K. Boyd

646 total citations
11 papers, 497 citations indexed

About

Lara K. Boyd is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cell Biology. According to data from OpenAlex, Lara K. Boyd has authored 11 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 3 papers in Cell Biology. Recurrent topics in Lara K. Boyd's work include Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Ubiquitin and proteasome pathways (2 papers). Lara K. Boyd is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Ubiquitin and proteasome pathways (2 papers). Lara K. Boyd collaborates with scholars based in United Kingdom, China and United States. Lara K. Boyd's co-authors include Xueying Mao, Yong‐Jie Lu, Daniel M. Berney, Sakunthala C. Kudahetti, Elzbieta Stankiewicz, R.T.D. Oliver, Tracy Chaplin, Bryan D. Young, Yongwei Yu and Luis Beltrán and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncotarget.

In The Last Decade

Lara K. Boyd

11 papers receiving 492 citations

Peers

Lara K. Boyd
Chuandong Geng United States
Suzan Stelloo Netherlands
A. Seun Ajiboye United States
S Whitney United States
Beatrice Babbs United States
Lara K. Boyd
Citations per year, relative to Lara K. Boyd Lara K. Boyd (= 1×) peers Kati Kivinummi

Countries citing papers authored by Lara K. Boyd

Since Specialization
Citations

This map shows the geographic impact of Lara K. Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara K. Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara K. Boyd more than expected).

Fields of papers citing papers by Lara K. Boyd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara K. Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara K. Boyd. The network helps show where Lara K. Boyd may publish in the future.

Co-authorship network of co-authors of Lara K. Boyd

This figure shows the co-authorship network connecting the top 25 collaborators of Lara K. Boyd. A scholar is included among the top collaborators of Lara K. Boyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara K. Boyd. Lara K. Boyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Mao, Xueying, Fei Luo, Lara K. Boyd, et al.. (2016). NKAIN2 functions as a novel tumor suppressor in prostate cancer. Oncotarget. 7(39). 63793–63803. 6 indexed citations
2.
Mao, Xueying, Jie Li, Lara K. Boyd, et al.. (2014). Involvement of different mechanisms for the association of CAG repeat length polymorphism in androgen receptor gene with prostate cancer.. PubMed. 4(6). 886–96. 12 indexed citations
3.
Boyd, Lara K., Xueying Mao, Liyan Xue, et al.. (2012). High‐resolution genome‐wide copy‐number analysis suggests a monoclonal origin of multifocal prostate cancer. Genes Chromosomes and Cancer. 51(6). 579–589. 50 indexed citations
4.
Boyd, Lara K., Xueying Mao, & Yong‐Jie Lu. (2012). The complexity of prostate cancer: genomic alterations and heterogeneity. Nature Reviews Urology. 9(11). 652–664. 154 indexed citations
5.
Lu, Yong‐Jie, Lara K. Boyd, Xueying Mao, et al.. (2011). Abstract 3048: Enhanced androgen signalling pathway increases the risk of prostate cancer through induction of TMPRSS2:ERG fusion. Cancer Research. 71(8_Supplement). 3048–3048. 1 indexed citations
6.
Mao, Xueying, Lara K. Boyd, Rafael J. Yáñez‐Muñoz, et al.. (2011). Chromosome rearrangement associated inactivation of tumour suppressor genes in prostate cancer.. PubMed. 1(5). 604–17. 34 indexed citations
7.
Boyd, Lara K., Xueying Mao, Elzbieta Stankiewicz, et al.. (2010). Androgen-Induced TMPRSS2:ERG Fusion in Nonmalignant Prostate Epithelial Cells. Cancer Research. 70(23). 9544–9548. 78 indexed citations
8.
Mao, Xueying, Yongwei Yu, Lara K. Boyd, et al.. (2010). Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis. Cancer Research. 70(13). 5207–5212. 126 indexed citations
9.
Boyd, Lara K., et al.. (2010). Characterisation of the SUMO-Like Domains of Schizosaccharomyces pombe Rad60. PLoS ONE. 5(9). e13009–e13009. 3 indexed citations
10.
Boyd, Lara K., Xueying Mao, & Yong‐Jie Lu. (2009). Use of SNPs in cancer predisposition analysis, diagnosis and prognosis: tools and prospects. Expert Opinion on Medical Diagnostics. 3(3). 313–326. 2 indexed citations
11.
Watts, Felicity Z., et al.. (2007). The role of Schizosaccharomyces pombe SUMO ligases in genome stability. Biochemical Society Transactions. 35(6). 1379–1384. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026